Boardroom Alpha
8-K primary document
ATOM · Current Report (Form 8-K) · Filed August 4, 2026

Atomera Inc8-K exhibit

atomera_ex9901.htm

Exhibit 99.1

 

 

 

Atomera Provides Second Quarter 2026 Results

 

LOS GATOS, Calif. Aug. 4, 2026 Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the second quarter ended June 30, 2026.

 

Recent Company Highlights

 

·Announced a new approach to GaN-on-Silicon that addresses a key performance barrier for RF applications
·Continued strong progress with GAA customers
·Growing interest from DRAM and flash memory providers

 

Management Commentary

 

“This quarter Atomera made excellent progress with customer engagements across our key target markets, in particular the advanced logic and memory segments where AI is creating the need for further performance improvements,” said Scott Bibaud, president and CEO of Atomera. ” In the past, RF designers have avoided using GaN for high volume applications because of the high cost and complexity of working with GaN on Silicon Carbide. Our breakthrough results with RF GaN on silicon have the potential to enable an entirely new class of RF devices which can now take advantage of the performance improvements GaN provides with the low cost of silicon substrates.”

 

Financial Results

 

The Company incurred a net loss of ($6.3) million, or ($0.17) per basic and diluted share in the second quarter of 2026, compared to a net loss of ($5.0) million, or ($0.17) per basic and diluted share, for the second quarter of 2025. Adjusted EBITDA (a non-GAAP financial measure) in the second quarter of 2026 was a loss of ($5.0) million compared to an adjusted EBITDA loss of ($4.0) million in the second quarter of 2025.

 

The Company had $38.4 million in cash, cash equivalents, and short-term investment as of June 30, 2026 compared to $19.2 million of cash and cash equivalents as of December 31, 2025.

 

The total number of shares outstanding was 39.0 million as of June 30, 2026.

 

 

 

 

 1 

 

 

Second Quarter 2026 Results Webinar

 

Atomera will host a live video webinar today to discuss its financial results and recent progress.

Date: Tuesday, Aug. 4, 2026

Time: 2:00 p.m. PT (5:00 p.m. ET)

Webcast: Accessible at https://ir.atomera.com

 

Note about Non-GAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company’s internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

 

About Atomera Incorporated

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap.  More information can be found at www.atomera.com.  

 

Safe Harbor

This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues thus subjecting us to all the risks inherent in an early-stage enterprise; (2) the risk that licensees or JDA customers do not advance to royalty-based manufacturing and distribution licenses; (3) our ability to add other licensees and/or JDA customers; (4) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (5) our ability to protect our proprietary technology, trade secrets and know-how and (6) those other risks disclosed in the section “Risk Factors” included in our Annual Report on Form 10-K filed with the SEC on February 24, 2026. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

 

– Financial Tables Follow –

 

 

 

 

 2 

 

 

Atomera Incorporated

Condensed Balance Sheets

(in thousands, except per share data)

 

         
   June 30,   December 31, 
   2026   2025 
    (Unaudited)      
ASSETS          
           
Current assets:          
Cash and cash equivalents  $15,146   $19,210 
Short-term investments   23,206     
Interest receivable   58    54 
Prepaid expenses and other current assets   542    338 
Total current assets   38,952    19,602 
           
Property and equipment, net   59    60 
Security deposit   14    14 
Operating lease right-of-use asset   1,128    884 
Financing lease right-of-use-asset   70    533 
           
Total assets  $40,223   $21,093 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
           
Current liabilities:          
Accounts payable  $569   $608 
Accrued expenses   297    168 
Accrued payroll related expenses   1,118    650 
Current operating lease liability   304    147 
Current financing lease liability       420 
Deferred Revenue       7 
Total current liabilities   2,288    2,000 
           
Long-term operating lease liability   860    712 
           
Total liabilities   3,148    2,712 
           
Commitments and contingencies        
           
Stockholders’ equity:          
Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of June 30, 2026 and December 31, 2025        
Common stock: $0.001 par value, authorized 47,500 shares; 39,024 shares issued and outstanding as of June 30, 2026; and 32,354 shares issued and outstanding as of December 31, 2025   39    32 
Additional paid in capital   291,157    260,043 
Other comprehensive income (loss)   (18)    
Accumulated deficit   (254,103)   (241,694)
Total stockholders’ equity   37,075    18,381 
Total liabilities and stockholders’ equity  $40,223   $21,093 

 

 

 

 3 

 

 

Atomera Incorporated

Condensed Statements of Operations

(Unaudited)

(in thousands, except per share data)

 

                 
   Three Months Ended   Six Months Ended 
   June 30,   March 31,   June 30,   June 30, 
   2026   2026   2025   2026   2025 
Revenue  $158   $11   $   $169   $4 
Cost of revenue   (26)   (126)   (62)   (152)   (62)
Gross margin   132    (115)   (62)   17    (58)
                          
Operating expenses                         
Research and development   3,287    3,457    3,004    6,744    6,259 
General and administrative   3,167    2,333    2,048    5,500    4,136 
Selling and marketing   437    419    141    856    265 
Total operating expenses   6,891    6,209    5,193    13,100    10,660 
                          
Loss from operations   (6,759)   (6,324)   (5,255)   (13,083)   (10,718)
                          
Other income (expense)                         
Interest income   172    197    234    369    504 
Accretion income   178    57        235    6 
Interest expense   (1)   (4)   (18)   (5)   (39)
Other income, net   74    1    72    75    71 
Total other income (expense), net   423    251    288    674    542 
                          
Net loss  $(6,336)  $(6,073)  $(4,967)  $(12,409)  $(10,176)
                          
Net loss per common share, basic and diluted  $(0.17)  $(0.17)  $(0.17)  $(0.34)  $(0.34)
                          
Weighted average number of common shares outstanding, basic and diluted   38,647    35,256    30,397    36,961    30,321 

 

 

 

 

 4 

 

 

Atomera Incorporated

Reconciliation to Non-GAAP EBITDA

(Unaudited)

 

                 
   Three Months Ended   Six Months Ended 
   June 30,   March 31,   June 30,   June 30, 
   2026   2026   2025   2026   2025 
Net loss (GAAP)  $(6,336)  $(6,073)  $(4,967)  $(12,409)  $(10,176)
Depreciation and amortization   6    9    12    15    24 
Stock-based compensation   1,741    1,406    1,278    3,147    2,287 
Interest income   (172)   (197)   (234)   (369)   (504)
Accretion income   (178)   (57)       (235)   (6)
Interest expense   1    4    18    5    39 
Other income, net   (74)   (1)   (72)   (75)   (71)
Net loss non-GAAP EBITDA  $(5,012)  $(4,909)  $(3,965)  $(9,921)  $(8,407)

 

 

 

 

Investor Contact:

Bishop IR

Mike Bishop

(415) 894-9633

investor@atomera.com

 

 

 

 

 

 

 

 

 

 

 5 

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer